GSA Capital Partners’s Biofrontera BFRI Stock Holding History
Bought
Maintained
Sold
Other funds holding BFRI
ACM
GSA Capital Partners's BFRI Position: Q3 2026 in Review
GSA Capital Partners sold out of Biofrontera (BFRI) in Q3 2026, closing a stake of 10,022 shares — an estimated $9K sold.
GSA Capital Partners first reported a position in BFRI in Q2 2026 and held it in 1 quarter. The position peaked at $9K in Q2 2026. 20 funds tracked by Wall St. Rank hold BFRI as of Q3 2026.
- GSA Capital Partners reported no remaining Biofrontera position as of Q3 2026 after selling out during the quarter.
- GSA Capital Partners sold 10,022 Biofrontera shares in Q3 2026, an estimated $9K.
- GSA Capital Partners first reported a position in Biofrontera in Q2 2026 and held it in 1 quarter.
- GSA Capital Partners's Biofrontera position peaked at $9K in Q2 2026.
- 20 funds tracked by Wall St. Rank held Biofrontera as of Q3 2026.
Based on GSA Capital Partners's 13F filing for Q3 2026, filed 16 Nov 2026.